Holen Sie sich die Stockscreener-App
14.94
1.08%
0.16
Handel nachbörslich:
14.92
-0.02
-0.13%
Finanzdaten der Intellia Therapeutics Inc-Aktie (NTLA)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
67.01%
23.02
|
13.78 | 14.24 | 16.63 | 9.111 |
Operating Expenses
|
2.82%
121.73
|
125.26 | 124.24 | 137.43 | 153.88 |
| Benefits Costs and Expenses |
5.15%
118.80
|
125.26 | 124.24 | 130.96 | 153.88 |
| Costs And Expenses |
2.82%
121.73
|
125.26 | 124.24 | 137.43 | 153.88 |
| Operating Income/Loss |
11.45%
-98.71
|
-111.48 | -110.00 | -120.81 | -144.77 |
| Income/Loss From Continuing Operations Before Tax |
14.08%
-95.79
|
-111.48 | -101.25 | -114.33 | -144.77 |
| Income/Loss From Continuing Operations After Tax |
5.47%
-95.79
|
-101.32 | -101.25 | -114.33 | -135.71 |
|
Net Income/Loss
|
5.47%
-95.79
|
-101.32 | -101.25 | -114.33 | -135.71 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
97.70%
2.535
|
110.19 | 103.73 | 103.50 | 101.00 |
| Diluted Average Shares |
97.70%
2.535
|
110.19 | 103.73 | 103.50 | 101.00 |
| Basic Earnings Per Share |
10.87%
-0.82
|
-0.92 | -0.98 | -1.10 | -1.34 |
| Diluted Earnings Per Share |
10.87%
-0.82
|
-0.92 | -0.98 | -1.10 | -1.34 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.69%
0.25%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):